Literature DB >> 29599117

Risk assessment in pulmonary arterial hypertension.

Marius M Hoeper1,2, David Pittrow3, Christian Opitz4, J Simon R Gibbs5, Stephan Rosenkranz6,7, Ekkehard Grünig2,8, Karen M Olsson9,2, Doerte Huscher10.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29599117     DOI： 10.1183/13993003.02606-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  21 in total

Review 1.  The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.

Authors:  Manreet Kanwar; Amresh Raina; Lisa Lohmueller; Jidapa Kraisangka; Raymond Benza
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

2.  Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension.

Authors:  Juan C Grignola; Enric Domingo; Manuel López-Meseguer; Pedro Trujillo; Carlos Bravo; Santiago Pérez-Hoyos; Antonio Roman
Journal:  Front Physiol       Date:  2021-05-03       Impact factor: 4.566

Review 3.  Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.

Authors:  Shu-Hao Wu; Yih-Jer Wu
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

4.  Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Authors:  Bradley A Maron; Steven H Abman; C Greg Elliott; Robert P Frantz; Rachel K Hopper; Evelyn M Horn; Mark R Nicolls; Oksana A Shlobin; Sanjiv J Shah; Gabor Kovacs; Horst Olschewski; Erika B Rosenzweig
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 30.528

Review 5.  The progress of pulmonary artery denervation.

Authors:  Yonghui Xie; Na Liu; Zhenghui Xiao; Fang Yang; Yunhong Zeng; Zhou Yang; Yuanxi Xia; Zhi Chen; Yunbin Xiao
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 3.487

6.  Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  Marc Humbert; Harrison W Farber; Hossein-Ardeschir Ghofrani; Raymond L Benza; Dennis Busse; Christian Meier; Marius M Hoeper
Journal:  Eur Respir J       Date:  2019-06-05       Impact factor: 16.671

7.  Risk stratification and medical therapy of pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Richard N Channick; Robert P Frantz; Ekkehard Grünig; Zhi Cheng Jing; Olga Moiseeva; Ioana R Preston; Tomas Pulido; Zeenat Safdar; Yuichi Tamura; Vallerie V McLaughlin
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

8.  Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.

Authors:  Panagiota Xanthouli; Maria Koegler; Alberto M Marra; Nicola Benjamin; Lukas Fischer; Christina A Eichstaedt; Satenik Harutyunova; Christian Nagel; Ekkehard Grünig; Benjamin Egenlauf
Journal:  Respir Res       Date:  2020-05-24

9.  Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.

Authors:  R James White; Carlos Jerjes-Sanchez; Gisela Martina Bohns Meyer; Tomas Pulido; Pablo Sepulveda; Kuo Yang Wang; Ekkehard Grünig; Shirish Hiremath; Zaixin Yu; Zhang Gangcheng; Wei Luen James Yip; Shuyang Zhang; Akram Khan; C Q Deng; Rob Grover; Victor F Tapson
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

10.  Congenital heart disease, pulmonary arterial hypertension and the UK's Drivers and Vehicle Licensing Agency: controversial new guidance.

Authors:  Andrew Constantine; Robert Tulloh; Robin Condliffe; Paul Clift; Konstantinos Dimopoulos
Journal:  Pulm Circ       Date:  2019-10-30       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.